Christopher Gregory Newton
Nessuna posizione attualmente
Profilo
Christopher Gregory Newton is the founder of Pulmagen Therapeutics (Synergy) Ltd.
which was founded in 2000.
He held the title of Chief Scientific Officer from 2000 to 2005.
Dr. Newton's former jobs include Director positions at Galapagos Biotech Ltd., Biofocus, Inc., Cangenix Ltd., BioFocus DPI AG, Inventiva SA, Argenta Discovery 2009 Ltd., BioFocus DPI (Holdings) Ltd., and Senior Vice President at Charles River Discovery Research Services UK Ltd.
He was also Senior Vice President-Galapagos Services at Galapagos NV from 2005 to 2012.
Dr. Newton's education history includes an undergraduate degree from the University of Cambridge and a doctorate from The University of Sheffield, which was conferred in 1979.
Precedenti posizioni note di Christopher Gregory Newton
| Società | Posizione | Fine |
|---|---|---|
| INVENTIVA | Direttore/Membro del Consiglio | 27/05/2019 |
| GALAPAGOS NV | Corporate Officer/Principal | 14/12/2012 |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Fondatore | 01/01/2005 |
| Rhône-Poulenc, Inc. | Corporate Officer/Principal | - |
| University of Essex | Corporate Officer/Principal | 01/01/1999 |
Formazione di Christopher Gregory Newton
| University of Cambridge | Undergraduate Degree |
| The University of Sheffield | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| INVENTIVA | Health Technology |
| Aziende private | 9 |
|---|---|
Charles River Discovery Research Services UK Ltd.
 Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Commercial Services |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
| Rhône-Poulenc, Inc. | Process Industries |
Biofocus, Inc.
 Biofocus, Inc. Pharmaceuticals: MajorHealth Technology Biofocus, Inc. operates as a clinical biotechnology company. The company is headquartered in the United Kingdom. | Health Technology |
Argenta Discovery 2009 Ltd.
 Argenta Discovery 2009 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Argenta Discovery 2009 Ltd. offers contract research drug discovery services. The company is based in Margate, UK. | Commercial Services |
BioFocus DPI (Holdings) Ltd.
 BioFocus DPI (Holdings) Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., BioFocus DPI (Holdings) Ltd. functions as an investment holding British company. The company is based in Margate, UK. | Finance |
Cangenix Ltd.
 Cangenix Ltd. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., Cangenix Ltd. is a British pharmaceutical company that manufactures and develops pharmaceutical products. The company is based in Ashford, UK. Cangenix was acquired by Galapagos NV on January 15, 2013 for $2.31 million. | Health Technology |
BioFocus DPI AG
 BioFocus DPI AG Miscellaneous Commercial ServicesCommercial Services BioFocus DPI AG provides research and development services. The private company is based in Allschwill, Switzerland and has subsidiaries in Germany. | Commercial Services |
- Borsa valori
- Insiders
- Christopher Gregory Newton
